Search by Drug Name or NDC

    NDC 73089-0325-21 VAZALORE 325 mg/325mg Details

    VAZALORE 325 mg/325mg

    VAZALORE is a ORAL CAPSULE in the HUMAN OTC DRUG category. It is labeled and distributed by PLx Pharma Inc. The primary component is ASPIRIN.

    Product Information

    NDC 73089-0325
    Product ID 73089-325_f1883355-2372-2a05-e053-2a95a90a278d
    Associated GPIs 64100010000115
    GCN Sequence Number 004361
    GCN Sequence Number Description aspirin CAPSULE 325 MG ORAL
    HIC3 H3D
    HIC3 Description ANALGESIC/ANTIPYRETICS, SALICYLATES
    GCN 16670
    HICL Sequence Number 001820
    HICL Sequence Number Description ASPIRIN
    Brand/Generic Brand
    Proprietary Name VAZALORE
    Proprietary Name Suffix n/a
    Non-Proprietary Name aspirin
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 325
    Active Ingredient Units mg/325mg
    Substance Name ASPIRIN
    Labeler Name PLx Pharma Inc
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203697
    Listing Certified Through 2024-12-31

    Package

    NDC 73089-0325-21 (73089032521)

    NDC Package Code 73089-325-21
    Billing NDC 73089032521
    Package 1 BOTTLE, PLASTIC in 1 CARTON (73089-325-21) / 325 mg in 1 BOTTLE, PLASTIC
    Marketing Start Date 2021-08-05
    NDC Exclude Flag N
    Pricing Information N/A